Source Natural Foods & Herbal Supplements Reaches All-Time High, Receives 'Hold' Recommendation from MarketsMOJO
Source Natural Foods & Herbal Supplements, a microcap company in the pharmaceuticals and drugs industry, has reached an all-time high stock price of Rs. 269.75 on October 20, 2024. Despite a recent dip, the stock is still trading higher than its moving averages and has outperformed the Sensex in the past year, showcasing its growth potential.
Source Natural Foods & Herbal Supplements, a microcap company in the pharmaceuticals and drugs industry, has recently seen a surge in its stock price. On October 20, 2024, the company's stock reached an all-time high of Rs. 269.75, breaking its previous 52-week high.
According to MarketsMOJO, a leading stock analysis and recommendation platform, the current stock call for Source Natural Foods & Herbal Supplements is 'Hold'. This suggests that investors should hold onto their shares and not make any immediate buying or selling decisions.
In terms of performance, Source Natural Foods & Herbal Supplements has underperformed the sector by -2.31% on the day of its all-time high. This could be due to profit-taking by investors after the stock's recent gains. It is worth noting that the stock has fallen after 7 consecutive days of gains, indicating a possible trend reversal.
Despite the recent dip, Source Natural Foods & Herbal Supplements is still trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a positive trend for the company's stock.
In the past year, Source Natural Foods & Herbal Supplements has outperformed the Sensex, with a 183.64% increase in its stock price compared to the Sensex's 23.30% performance. This showcases the company's strong growth potential and its ability to outperform the market.
Overall, Source Natural Foods & Herbal Supplements has shown promising performance in the past year and has reached a new milestone with its all-time high stock price. With a 'Hold' recommendation from MarketsMOJO, investors may want to keep an eye on this microcap company in the pharmaceuticals and drugs industry.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
